Uneven Ground: Survival Differences Among Victorian Lung Cancer Patients by Location of Residence (2011–2023): A Retrospective Cohort Study
Medical Journal of Australia · 2026
DOI: 10.5694/mja2.70268 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Medical Journal of Australia, 2026. Verfasst von Evangeline Samuel und 20 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Rural Population, Urban Population. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objectives
Patients in regional and rural areas consistently experience poorer lung cancer survival rates compared with those in metropolitan centres, but the reasons remain unclear. This study examined survival differences in non‐small cell lung cancer (NSCLC) across Victoria and identified key prognostic factors contributing to these differences.
Design
Retrospective cohort study. Setting and Participants NSCLC patients diagnosed between 1 July 2011 and 22 May 2023 identified from the Victorian Lung Cancer Registry (VLCR). Main Outcome Measures Residential address and treatment institution were classified using the Modified Monash Model (MMM): Modified Monash (MM) category 1 (MM1) as metropolitan, MM2 as regional and MM3–MM7 as rural/remote. Demographic, socio‐economic and cancer‐specific factors were analysed as potential predictors of all‐cause mortality.
Results
Among 13,548 patients, 4244 (31%) lived in regional or rural/remote areas. Compared with metropolitan patients, these groups had higher smoking prevalence (metropolitan, 2848/9304 [31%] vs. regional, 366/1083 [34%] vs. rural, 1148/3161 [37%]) and were more likely to be Australian‐born (metropolitan, 4919/9304 [53%] vs. regional, 873/1083 [81%] vs. rural, 2603/3161 [82%]; p < 0.001). Comorbidity burden was similar across groups (median, 1; interquartile range, 0.0–1.0; p = 0.19). Socio‐economic disadvantage was more marked in regional and rural patients (median Index of Relative Socio‐Economic Advantage and Disadvantage [IRSAD] deciles: metropolitan, 8.0 vs. regional, 5.0 vs. rural, 3.0; p < 0.001), and average travel times to treatment were longer (metropolitan, 0.4 vs. regional, 1.9 vs. rural, 2.8 h, respectively). Patients treated at regional institutions had poorer survival (hazard ratio [HR], 1.27; 95% confidence interval [CI], 1.19–1.35; p < 0.001). This difference persisted after adjustment for age, stage, performance status, smoking and comorbidities (HR, 1.11; 95% CI, 1.04–1.18; p = 0.001).
Conclusions
Regional, rural and remote patients with NSCLC face greater socio‐economic disadvantage and travel burdens, and experience poorer survival even after accounting for clinical and demographic factors. These findings highlight enduring inequities in lung cancer care and emphasise the need for targeted interventions to strengthen access, treatment equity and outcomes for non‐metropolitan populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
- Department of Medical Oncology, Latrobe Health Services, Traralgon, Victoria, Australia.
- Department of Medical Oncology, Alfred Health, Melbourne, Victoria, Australia.
- Border Medical Oncology Research Unit, Albury Wodonga Regional Cancer Centre, Albury, New South Wales, Australia.
- Rural Medical School Albury, UNSW Sydney, Albury, New South Wales, Australia.
- Olivia Newton-John Cancer Wellness and Research Centre, Melbourne, Victoria, Australia.
ORCID-Profile: Rob G Stirling
Zitieren
APA
Samuel, E., Paul, E., Lloyd, M., Tissera, S., Underhill, C., Parakh, S., Parente, P., Olesen, I., Torres, J., See, K., Wright, G. M., Langton, D., John, T., Conron, M., Bartlett, J., Atkin, N., Zeps, N., Harden, S. V., Faisal, W., …, & Stirling, R. G. (2026). Uneven Ground: Survival Differences Among Victorian Lung Cancer Patients by Location of Residence (2011–2023): A Retrospective Cohort Study. Medical Journal of Australia. https://doi.org/10.5694/mja2.70268
Vancouver
Samuel E, Paul E, Lloyd M, Tissera S, Underhill C, Parakh S, et al. Uneven Ground: Survival Differences Among Victorian Lung Cancer Patients by Location of Residence (2011–2023): A Retrospective Cohort Study. Medical Journal of Australia. 2026. doi:10.5694/mja2.70268
BibTeX
@article{Samuel2026,
author = {Samuel, Evangeline and Paul, Eldho and Lloyd, Mike and Tissera, Sanuki and Underhill, Craig and Parakh, Sagun and Parente, Phillip and Olesen, Inger and Torres, Javier and See, Katharine and Wright, Gavin M and Langton, David and John, Thomas and Conron, Matthew and Bartlett, James and Atkin, Nicola and Zeps, Nikolajs and Harden, Susan V and Faisal, Wasek and Zalcberg, John R and Stirling, Rob G},
title = {Uneven Ground: Survival Differences Among Victorian Lung Cancer Patients by Location of Residence (2011–2023): A Retrospective Cohort Study},
journal = {Medical Journal of Australia},
year = {2026},
doi = {10.5694/mja2.70268}
}
EUVIMED